| 28th Apr 2025 11:30 am |
RNS |
Result of General Meeting |
| 23rd Apr 2025 7:00 am |
RNS |
Proposed acquisition of Awakn approved |
| 16th Apr 2025 7:00 am |
RNS |
Final Results for the year ended 31 December 2024 |
| 10th Apr 2025 2:00 pm |
RNS |
Posting of Circular and Notice of General Meeting |
| 7th Apr 2025 7:00 am |
RNS |
Holding(s) in Company |
| 4th Apr 2025 7:00 am |
RNS |
Engagement of PharmaVentures |
| 26th Mar 2025 7:00 am |
RNS |
Positive progress on European Patent Application |
| 18th Mar 2025 7:00 am |
RNS |
Update on AWKN-SDN-14 programme |
| 11th Mar 2025 9:00 am |
RNS |
Holding(s) in Company |
| 11th Mar 2025 7:00 am |
RNS |
Appointment of Non-Executive Director |
| 25th Feb 2025 7:00 am |
RNS-R |
Presentation at PharmaSynergyRx Event |
| 24th Feb 2025 7:00 am |
RNS |
Entry into an Arrangement Agreement with Awakn |
| 30th Jan 2025 12:00 pm |
RNS-R |
Proactive Investors interview with Chairman |
| 27th Jan 2025 7:00 am |
RNS |
Update on Awakn Life Sciences’ R&D Progress |
| 24th Jan 2025 7:00 am |
RNS-R |
Investor Presentation |
| 21st Jan 2025 2:29 pm |
RNS-R |
Proactive Investors interview with CEO |
| 21st Jan 2025 7:00 am |
RNS |
Update on FDA Pre-IND Meeting for Awakn |
| 15th Jan 2025 7:00 am |
RNS-R |
Interview with CEO |
